findmyKOL
Clinical trialNCT00947596CompletedPhase 1Interventional

A Study of Inhaled Atropine Sulfate in Healthy Adults

SponsorMicroDose Defense Products L.L.C.Enrollment18Organophosphorus Poisoning
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by the ADPI to atropine delivery from the AtroPen autoinjector.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Michael Donahoe, M.D.

    Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh

    Principal Investigator
  • Timothy Corcoran, Ph.D.

    Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Montefiore Hospital Clinical and Translational Research Center

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2009
Primary completion
31 Jul 2010
Completion
31 Aug 2010
Last update posted
12 Aug 2010
Registered enrollment
18
Registry id
NCT00947596

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.